vs
Foghorn Therapeutics Inc.（FHTX）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是Foghorn Therapeutics Inc.的1.5倍（$14.0M vs $9.2M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -234.3%，领先244.1%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs 10.4%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs 24.6%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
FHTX vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.5倍
$9.2M
营收增速更快
FHTX
高出213.4%
10.4%
净利率更高
RVSB
高出244.1%
-234.3%
两年增速更快
FHTX
近两年复合增速
24.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $14.0M |
| 净利润 | $-21.7M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -258.2% | 12.4% |
| 净利率 | -234.3% | 9.8% |
| 营收同比 | 223.8% | 10.4% |
| 净利润同比 | -11.1% | 11.8% |
| 每股收益（稀释后） | $-0.35 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXRVSB
| Q4 25 | $9.2M | $14.0M | ||
| Q3 25 | $8.2M | $13.6M | ||
| Q2 25 | $7.6M | $13.3M | ||
| Q1 25 | $6.0M | $12.9M | ||
| Q4 24 | $2.9M | $12.7M | ||
| Q3 24 | $7.8M | $12.8M | ||
| Q2 24 | $6.9M | $12.2M | ||
| Q1 24 | $5.0M | $9.0M |
净利润FHTXRVSB
| Q4 25 | $-21.7M | $1.4M | ||
| Q3 25 | $-15.8M | $1.1M | ||
| Q2 25 | $-17.9M | $1.2M | ||
| Q1 25 | $-18.8M | $1.1M | ||
| Q4 24 | $-19.5M | $1.2M | ||
| Q3 24 | $-19.1M | $1.6M | ||
| Q2 24 | $-23.0M | $966.0K | ||
| Q1 24 | $-25.0M | $-3.0M |
营业利润率FHTXRVSB
| Q4 25 | -258.2% | 12.4% | ||
| Q3 25 | -226.9% | 10.2% | ||
| Q2 25 | -279.2% | 11.7% | ||
| Q1 25 | -385.0% | 11.3% | ||
| Q4 24 | -840.5% | 12.4% | ||
| Q3 24 | -305.5% | 15.5% | ||
| Q2 24 | -386.6% | 10.0% | ||
| Q1 24 | -558.3% | -47.5% |
净利率FHTXRVSB
| Q4 25 | -234.3% | 9.8% | ||
| Q3 25 | -194.4% | 8.1% | ||
| Q2 25 | -237.3% | 9.2% | ||
| Q1 25 | -316.4% | 8.9% | ||
| Q4 24 | -682.9% | 9.7% | ||
| Q3 24 | -244.9% | 12.2% | ||
| Q2 24 | -333.6% | 7.9% | ||
| Q1 24 | -495.4% | -34.7% |
每股收益（稀释后）FHTXRVSB
| Q4 25 | $-0.35 | $0.07 | ||
| Q3 25 | $-0.25 | $0.05 | ||
| Q2 25 | $-0.28 | $0.06 | ||
| Q1 25 | $-0.30 | $0.05 | ||
| Q4 24 | $-0.23 | $0.06 | ||
| Q3 24 | $-0.31 | $0.07 | ||
| Q2 24 | $-0.45 | $0.05 | ||
| Q1 24 | $-0.59 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-108.5M | $164.2M |
| 总资产 | $198.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FHTXRVSB
| Q4 25 | $80.9M | $28.6M | ||
| Q3 25 | $89.3M | $32.8M | ||
| Q2 25 | $72.6M | $34.2M | ||
| Q1 25 | $61.0M | $29.4M | ||
| Q4 24 | $55.5M | $25.3M | ||
| Q3 24 | $57.7M | $31.0M | ||
| Q2 24 | $138.9M | $27.8M | ||
| Q1 24 | $79.3M | $23.6M |
股东权益FHTXRVSB
| Q4 25 | $-108.5M | $164.2M | ||
| Q3 25 | $-89.7M | $163.5M | ||
| Q2 25 | $-76.7M | $162.0M | ||
| Q1 25 | $-61.7M | $160.0M | ||
| Q4 24 | $-45.5M | $158.3M | ||
| Q3 24 | $-28.3M | $160.8M | ||
| Q2 24 | $-14.3M | $155.9M | ||
| Q1 24 | $-97.5M | $155.6M |
总资产FHTXRVSB
| Q4 25 | $198.1M | $1.5B | ||
| Q3 25 | $205.0M | $1.5B | ||
| Q2 25 | $226.2M | $1.5B | ||
| Q1 25 | $258.7M | $1.5B | ||
| Q4 24 | $284.0M | $1.5B | ||
| Q3 24 | $308.4M | $1.5B | ||
| Q2 24 | $328.6M | $1.5B | ||
| Q1 24 | $255.0M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-736.0K |
| 自由现金流率自由现金流/营收 | — | -5.2% |
| 资本支出强度资本支出/营收 | 0.0% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流FHTXRVSB
| Q4 25 | $-22.3M | $-506.0K | ||
| Q3 25 | $-18.9M | $16.8M | ||
| Q2 25 | $-21.0M | $-697.0K | ||
| Q1 25 | $-24.0M | $8.3M | ||
| Q4 24 | $-24.5M | $2.2M | ||
| Q3 24 | $-21.0M | $764.0K | ||
| Q2 24 | $-25.5M | $5.4M | ||
| Q1 24 | $-29.3M | $12.8M |
自由现金流FHTXRVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | $-21.0M | $-773.0K | ||
| Q1 25 | $-24.0M | $5.6M | ||
| Q4 24 | $-25.0M | $1.9M | ||
| Q3 24 | $-21.3M | $-1.4M | ||
| Q2 24 | $-25.6M | $5.3M | ||
| Q1 24 | $-29.4M | $7.1M |
自由现金流率FHTXRVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | -278.2% | -5.8% | ||
| Q1 25 | -403.2% | 43.1% | ||
| Q4 24 | -875.3% | 15.0% | ||
| Q3 24 | -273.0% | -11.3% | ||
| Q2 24 | -371.0% | 43.7% | ||
| Q1 24 | -583.1% | 79.0% |
资本支出强度FHTXRVSB
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | 0.3% | 0.6% | ||
| Q1 25 | 0.5% | 21.0% | ||
| Q4 24 | 16.8% | 2.4% | ||
| Q3 24 | 4.0% | 17.3% | ||
| Q2 24 | 0.2% | 0.9% | ||
| Q1 24 | 2.0% | 62.0% |
现金转化率FHTXRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
